Companies: 10,795·Total market cap: $144.5T

Bioventus Inc.

Bioventus Inc.

BVSNASDAQHealthcare● Active

$9.04

+$0.34(+3.91%)

Market Cap$612442354

P/E Ratio—

52W High$11.249

52W Low$5.81

Avg Volume552K

Open$8.85

Beta0.67

股票排行：Medical - Devices·Healthcare·查看全部市值排行 →

Bioventus Inc.（BVS）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · BVS · 截至 Jun 8, 2026

关键指标

EPS (TTM)$0.42Earnings history

PE Ratio (TTM)21.4×PE Ratio deep dive

Revenue (TTM)$576.3MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding66.6MShares outstanding history

Next EarningsAug 5, 2026Est.Earnings history

探索 Bioventus Inc. 数据

分析师预测$13 · Buy

股息不分红

营收$568.1M-0.91%

盈利EPS $0.34+165.38%

市盈率21.4×

财务快照

FY 2025Revenue$568.1M▼ 0.91% YoY

202320242025

FY 2025Net Income$22.7M▲ +167.77% YoY

202320242025

FY 2025EPS$0.34▲ +165.38% YoY

202320242025

TTM:Revenue: $576.3MNet Income: $28.5MEPS: $0.42View income statement →

分析师评级与目标价

Buy6 位分析师

Strong Buy

0

Buy

4

Hold

2

Sell

0

Strong Sell

0

12-Month Price Target

$13.00Low

$9.04Current

$13.00Avg Target上涨空间 43.81%

$13.00High

合计: 6 · 买入占比: 66.7%

根据过去 3 个月内 6 位华尔街分析师，BVS 共识评级为 Buy，12 个月平均目标价 $13.00 （较现价 $9.04 上涨空间 43.81%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

$9.04+3.91%$612.4M #2

Avanos Medical, Inc.

$25.05+0.20%$1.2B #3

Butterfly Network, Inc.

$4.57-11.95%$1.2B #4

$18.25-2.67%$692.5M #5

Cytek Biosciences, Inc.

$4.09-5.54%$528.2M #6

OrthoPediatrics Corp.

$18.32+1.22%$470.5M

股票表现

1D+3.91%

1W+11.19%

1M-13.90%

3M+7.49%

YTD+21.51%

1Y+34.52%

5Y-47.78%

关于 Bioventus Inc.

CEORobert E. Claypoole

IPO DateFeb 11, 2021

Employees930

CountryUS

Websitebioventus.com

Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and international…

Medical - Devices HealthcareNASDAQUS

关于股票概览与关键数据

Bioventus Inc.（BVS）是 Medical - Devices 行业的 Healthcare 类公司，于 Feb 11, 2021 在 NASDAQ 上市。截至最近交易日，BVS 股价为 $9.04，市值约为 $612.4M。过去12个月累计回报 +34.52%，年初至今回报 +21.51%。

根据 6 位华尔街分析师，Bioventus Inc. 股票共识评级为Buy，12个月平均目标价为 $13.00。2025 财年 Bioventus Inc. 营收 $568.1M，净利润 $22.7M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Bioventus Inc.（BVS）股价为 $9.04，在 NASDAQ 上市，52周区间为 $5.81 – $11.25。

BVS 最新股价BVS quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议